Membrane lipidomics for personalized health

Membrane Lipidomics for Personalized Health

Volumn , Issue , 2015, Pages 1-184

  Ferreri, Carla ^a   Chatgilialoglu, Chryssostomos ^b  

^a CNR   (Italy)

^b INSTITUTE OF NANOSCIENCE AND NANOTECHNOLOGY   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84944316942     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9781118683682     Document Type: Book

References (209)

1. Kamphorst, J. J., Cross, J. R., Fan, J., et al. (2013) Hypoxic and Ras-transformed cells support growth by scavenging unsaturated fatty acids from lysophospholipids. Proceedings of the National Academy of Sciences of the United States of America, 110, 8882-8887.
2. Mouritsen, O. G. (2005) Life-As a Matter of Facts: The Emerging Science of Lipidomics. Springer-Verlag, Berlin.
3. Coskun, Ü., Simons, K. (2011) Cell membranes: the lipid perspective. Structure, 19, 1543-1548.
4. Nagle, J. F., Tristram-Nagle, S. (2000) Structure of lipid bilayers. Biochimica et Biophysica Acta, 1469, 159-195.
5. Rawizcz, W., Olbrich, K. C., McIntosh, T., Needham, D., Evans, E. (2000) Effect of chain length and unsaturation on elasticity of lipid bilayers. Biophysical Journal, 79, 328-339.
6. Rawizcz, W., Smith, B. A., McIntosh, T. J., Simon, S. A., Evans, E. (2008) Elasticity, strength, and water permeability of bilayers that contain raft microdomain-forming lipids. Biophysical Journal, 94, 4725-4736.
7. For tutorial of the membrane formation processes see the following website: http:// exploringorigins.org/fattyacids.html.
8. Vergne, I., Deretic, V. (2010) The role of PI3P phosphatases in the regulation of autophagy. FEBS Letters, 584, 1313-1318.
9. Lindmo, K., Stenmark, H. (2006) Regulation of membrane traffic by phosphoinositide 3-kinases. Journal of Cell Science, 119, 605-614.
10. Fahy, E., Subramaniam, S., Murphy, R. C., et al. (2009) Update of the LIPID MAPS comprehensive classification system for lipids. Journal of Lipid Research, 50, S9-S14.
11. Chatgilialoglu, C., Ferreri, C., Melchiorre, M., Sansone, A., Torreggiani A. (2014) Lipid geometrical isomerism: from chemistry to biology and diagnostics. Chemical Reviews, 114, 255-284.
12. Cevc, G. (1991) How membrane chain-melting phase-transition temperature is affected by the lipid chain asymmetry and degree of saturation-an effective chainlength model. Biochemistry, 30, 7186-7193.
13. Ferreri, C., Pierotti, S., Barbieri, A., et al. (2006) Comparison of phosphatidylcholine vesicle properties related to geometrical isomerism. Photochemistry and Photobiology, 82, 274-280.
14. Ferreri, C., Pierotti, S., Chatgilialoglu, C., Barbieri, A., Barigelletti, F. (2006) Probing the influence of cis-trans isomers on model lipid membrane fluidity using cis-parinaric acid and stop-flow technique. Chemical Communications, 5, 529-531.
15. Angell, S. Y., Cobb, L. K., Curtis, C. J., Konty, K. J., Silver, L. D. (2012) Change in trans fatty acid content of fast-food purchases associated with New York City's restaurant regulation: a pre-post study. Annals of Internal Medicine, 157, 81-86.
16. Ferreri, C., Grabovskiy, S., Aoun, M., et al. (2012) Mono-trans eicosapentaenoic acid isomer library: a dual synthetic strategy and follow-up of rats fed deodorized fish oil diets. Chemical Research in Toxicology, 25, 687-694.
17. See website for membrane simulation: http://blanco.biomol.uci.edu/bilayer_struc. html.
18. Hulbert, A. J. (2007) Membrane fatty acids as pacemakers of animal metabolism. Lipids, 42, 811-819.
19. Lasic, D. D., Papahadjopoulos, D. (eds.) (1998) Medical Applications of Liposomes. Elsevier Press, Amsterdam.
20. Lingwood, D., Binnington, B., Róg, T., et al. (2011) Cholesterol modulates glycolipid conformation and receptor activity. Nature Chemical Biology, 7, 260-262.
21. Martinez-Seara, H., Róg, T., Karttunen, M., Vattulainen, I., Reigada, R. (2010) Cholesterol induces specific spatial and orientational order in cholesterol/ phospholipid membranes. PLoS ONE, 5(6), e11162. doi: 10.1371/journal.pone. 0011162.
22. Aro, A., Jauhiainen, M., Partanen, R., Salminen, I., Mutanen, M. (1997) Stearic acid, trans fatty acids, and dairy fat: effects on serum and lipoprotein lipids, apolipoproteins, lipoprotein(a), and lipid transfer protein in healthy subjects. American Journal of Clinical Nutrition, 65, 1419-1426.
23. Simons, K., Toomre, D. (2000) Lipid rafts and signal transduction. Nature Reviews Molecular Cell Biology, 1, 31-39.
24. Alò, P. L., Visca, P., Marci, A., et al. (1996) Expression of fatty acid synthase (FAS) as a predictor of recurrence in stage I breast carcinoma patients. Cancer, 77, 474-482.
25. Migita, T., Fornari, A., Fiorentino, M., et al. (2009) Fatty acid synthase: a metabolic enzyme and candidate oncogene in prostate cancer. Journal of the National Cancer Institute, 101, 519-532.
26. Jakobsson, A., Westerberg, R., Jacobsson, A. (2006) Fatty acid elongases in mammals: their regulation and roles in metabolism. Progress in Lipid Research, 45, 237-249.
27. Leonard, A. E., Pereira, S. L., Sprecher, H., Huang, Y. S. (2004) Elongation of longchain fatty acids. Progress in Lipid Research, 43, 36-54.
28. Moser, A. B., Kreiter, N., Bezman, L., et al. (1999) Plasma very long chain fatty acids in 3,000 peroxisome disease patients and 29,000 controls. Annals of Neurology, 45, 100-110.
29. Aslibekyan, S., Jensen, M. K., Campos, H., et al. (2012) Genetic variation in fatty acid elongases is not associated with intermediate cardiovascular phenotypes or myocardial infarction. European Journal of Clinical Nutrition, 66, 353-359.
30. Guillou, H., Zadravec, D., Martin, P. G. P., Jacobsson, A. (2010) The key roles of elongases and desaturases in mammalian fatty acid metabolism: insights from transgenic mice. Progress in Lipid Research, 49, 186-199.
31. Joint WHO/FAO Expert Consultation (2003) Diet, Nutrition and the Prevention of Chronic Diseases (WHO technical report series 916). World Health Organization, Geneva, pp. 81-94.
32. EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA) (2011) Scientific Opinion on the substantiation of health claims related to the replacement of mixtures of saturated fatty acids (SFAs) as present in foods or diets with mixtures of monounsaturated fatty acids (MUFAs) and/or mixtures of polyunsaturated fatty acids (PUFAs), and maintenance of normal blood LDL-cholesterol concentrations (ID 621, 1190, 1203, 2906, 2910, 3065) pursuant to Article 13(1) of Regulation (EC) No 1924/2006. EFSA Journal, 9(4), 2069.
33. Siri-Tarino, P. W., Sun, Q., Hu, F. B., Krauss, R. M. (2010) Meta-analysis of prospective cohort studies evaluating the association of saturated fat with cardiovascular disease. American Journal of Clinical Nutrition, 91, 535-546.
34. Cao, H., Gerhold, K., Mayers, J. R., et al. (2008) Identification of a lipokine, a lipid hormone linking adipose tissue to systemic metabolism. Cell, 134, 933-944.
35. Sansone, A., Melchiorre, M., Chatgilialoglu, C., Ferreri, C. (2013) Hexadecenoic fatty acid isomers: a chemical biology approach for human plasma biomarker development. Chemical Research in Toxicology, 26, 1703-1709.
36. Lauritzen, L., Hansen, H. S., Jorgensen, M. H., Michaelsen, K. F. (2001) The essentiality of long chain n-3 fatty acids in relation to development and function of the brain and retina. Progress in Lipid Research, 40, 1-94.
37. Burr, G. O., Burr, M. M., Miller, E. (1930) On the nature and role of the fatty acids essential in nutrition. Journal of Biological Chemistry, 86, 1-9.
38. Glaser, C., Lattka, E., Rzehak, P., Steer, C., Koletzko, B. (2011) Genetic variation in polyunsaturated fatty acid metabolism and its potential relevance for human development and health. Maternal & Child Nutrition, 7(Suppl. 2), 27-40. doi: 10.1111/j.1740-8709.2011.00319.x.
39. Schaeffer, L., Gohlke, H., Müller, M., et al. (2006) Common genetic variants of the FADS1 FADS2 gene cluster and their reconstructed haplotypes are associates with the fatty acid composition in phospholipids. Human Molecular Genetics, 15, 1745-1756.
40. Wang, X., Lin H., Gu, Y. (2012) Multiple roles of dihomo-γ-linolenic acid against proliferation diseases. Lipids in Health and Disease, 11, 25. doi: 10.1186/1476-511X-11-25.
41. Burge, G. (2004) Alpha-linolenic acid metabolism in men and women: nutritional and biological implications. Current Opinion in Clinical Nutrition & Metabolism Care, 7, 137-144.
42. Brenna, J. T., Salem Jr., N., Sinclair, A. J., Cunnane, S. C. (2009) α-Linolenic acid supplementation and conversion to n-3 long-chain polyunsaturated fatty acids in humans. Prostaglandins, Leukotrienes, and Essential Fatty Acids, 80, 85-91.
43. Bannenberg, G., Serhan, C. N. (2010) Specialized pro-resolving lipid mediators in the inflammatory response: an update. Biochimica et Biophysica Acta, 1801, 1260-1273.
44. Serhan, C. N., Petasis, N. A. (2011) Resolvins and protectins in inflammation resolution. Chemical Reviews, 111, 5922-5943.
45. Lankinen, M., Schwab, U., Erkkilä, A., et al. (2009) Fatty fish intake decreases lipids related to inflammation and insulin signaling-a lipidomics approach. PLoS ONE, 4(4), e5258. doi: 10.137/journal.pone.0005258.
46. Sanders, T. A. B. (2009) DHA status of vegetarians. Prostaglandins, Leukotrienes, and Essential Fatty Acids, 81, 137-141.
47. Harris, W. S. (2007) Omega-3 fatty acids and cardiovascular disease: a case for omega-3 index as a new risk factor. Pharmacological Research, 55, 217-223.
48. Park, Y., Lim, J., Lee, J., Kim, S. G. (2009) Erythrocyte fatty acid profiles can predict acute non-fatal myocardial infarction. British Journal of Nutrition, 102, 1355-1356.
49. Pottala, J. V., Garg, S., Cohen, B. E., et al. (2010) Blood eicosapentaenoic and docosahexaenoic acids predict all-cause mortality in patients with stable coronary heart disease: the heart and soul study. Circulation, 3, 406-412.
50. Calder, P. C. (2012) Omega-3 polyunsaturated fatty acids: nutrition or pharmacology? British Journal of Clinical Pharmacology, 75, 645-672.
51. Calder, P. C. (2009) Polyunsaturated fatty acids and inflammatory processes: new twists of an old tale? Biochimie, 91, 791-795.
52. Hishikawa, D., Hashidate, T., Shimizu, T., Shindou, H. (2014) Diversity and functions of membrane glycerophospholipids generated by the remodelling pathway in mammalian cells. Journal of Lipid Research, 55, 799-807.
53. Lands, W. E. M. (1958) Metabolism of glycerolipides: a comparison of lecithin and triglyceride synthesis. Journal of Biological Chemistry, 231, 883-888.
54. Fan, Y.-Y., Chapkin, R. S. (1998) Importance of dietary γ-linolenic acid in human health and nutrition. Journal of Nutrition, 128, 1411-1414.
55. Database for food compositions can be found in various websites, such as: United States Department of Agriculture (USDA, USA). http://ndb.nal.usda.gov;
56. European Database (EuroFir). http://www.eurofir.org.
57. Simopoulos, A. P. (2002) The importance of the ratio of omega-6/omega-3 essential fatty acids. Biomedicine & Pharmacotherapy, 56, 365-379.
58. From the Lecture given by Prof. A. P. Simopoulos on April 17, 2010; posted in the website: www.helleniklink.org.
59. EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA) (2010) Scientific opinion on Dietary Reference values for fats, including saturated fatty acids, polyunsaturated fatty acids, monounsaturated fatty acids, trans fatty acids, and cholesterol. EFSA Journal, 8, 1461.
60. Ferreri, C., Chatgilialoglu, C. (2012) Role of fatty acid-based functional lipidomics in the development of molecular diagnostic tools. Expert Review of Molecular Diagnostics, 12, 767-780.
61. Atilla-Gokcumen, G. E., Muro, E., Relat-Goberna, J., et al. (2014) Dividing cells regulate their lipid composition and localization. Cell, 156, 428-439.
62. Micha, R., King, I. B., Lemaitre, R. N., et al. (2010) Food sources of individual plasma phospholipid trans fatty acid isomers: the Cardiovascular Health Study. American Journal of Clinical Nutrition, 91, 883-889.
63. Craig-Schmidt, M. C. (2006) World-wide consumption of trans fatty acids. Atherosclerosis, 7, 1-8.
64. Brouwer, I. A., Wanders, A. J., Katan, M. B. (2013) Trans fatty acids and cardiovascular health: research completed? European Journal of Clinical Nutrition, 67, 541-547.
65. Department of Health and Human Services, FDA. (2003) Food labeling: trans fatty acids in nutrition labeling; nutrient content claims, and health claims: final rule. Federal Register, 68, 41433.
66. Stender, S., Astrup, A., Dyeberg, J. (2012) A trans European Union difference in the decline in trans fatty acids in popular foods: a market basket investigation. BMJ Open, 2, 5e000859. doi: 10.1136/bmjopen-2012-000859.
67. Simopoulos, A. P. (2008) The omega-6/omega-3 fatty acid ratio, genetic variation, and cardiovascular disease. Asia Pacific Journal of Clinical Nutrition, 17, S131134.
68. Aoun, M., Feillet-Coudray, C., Fouret, G., et al. (2012) Rat liver mitochondrial membrane characteristics and mitochondrial functions are more profoundly altered by dietary lipid quantity than by dietary lipid quality: effect of different nutritional lipid patterns. British Journal of Nutrition, 107, 647-659.
69. Mozaffarian, D., Rimm, E. B. (2006) Fish intake, contaminants, and human health evaluating the risks and the benefits. Journal of the American Medical Association, 296, 1885-1899.
70. Wall, R., Ross, R. P., Fitzgerald, G. F., Stanton, C. (2010) Fatty acids from fish: the anti-inflammatory potential of long-chain omega-3 fatty acids. Nutrition Reviews, 68, 280-289.
71. Simopoulos, A. P. (2011) Evolutionary aspects of diet: the omega-6/omega-3 ratio and the brain. Molecular Neurobiology, 44, 203-215.
72. Zhang, C., Bazan, N. G. (2010) Lipid-mediated cell signaling protects against injury and neurodegeneration. Journal of Nutrition, 140, 858-863.
73. Sébédio, J. L., Christie, W. W. (2009) Metabolism of trans fatty acid isomers, in: Trans Fatty Acids in Human Nutrition, 2nd ed. (eds. F. Destaillats, J. L. Sébédio, F. Dionisi, J.-M. Chardigny). The Oily Press, Ltd, Bridgewater, pp. 163-194.
74. Pariza, M. W., Park, Y., Cook, M. E. (2001) The biologically active isomers of conjugated linoleic acid. Progress in Lipid Research, 40, 283-298.
75. Ferreri, C., Chatgilialoglu, C. (2012) Lipid isomerization, in Encyclopedia of Radical in Chemistry, Biology & Materials (eds. C. Chatgilialoglu, A. Studer). John Wiley & Sons, Ltd, Chichester, pp. 1599-1622.
76. Heipieper, H. J., Fisher, J. (2010) Bacterial solvent responses and tolerance: cis-trans isomerization, in: Handbook of Hydrocarbon and Lipid Microbiology (ed. K. N. Timmis). Springer Verlag, Berlin, pp. 4203-4211.
77. Higdon, A., Diers, A. R., Oh, J. Y., Landar A., Darley-Usmar V. M. (2012) Cell signalling by reactive lipid species: new concepts and molecular mechanisms. Biochemical Journal, 442, 453-464.
78. Cohen, G., Riahi, Y., Sunda, V., et al. (2013) Signaling properties of 4-hydroxyalkenals formed by lipid peroxidation in diabetes. Free Radical Biology & Medicine, 65, 978-987.
79. Schopfer, F. J., Cipollina, C., Freeman, B. A. (2011) Formation and signaling actions of electrophilic lipids. Chemical Reviews, 111(10), 5997-6021.
80. Murphy, M. P., Holmgren, A., Larsson, N.-G., et al. (2011) Unraveling the biological roles of reactive oxygen species. Cell Metabolism, 13(4), 361-366.
81. Cohen, G., Riahi, Y., Shamni, O., et al. (2011) The role of lipid peroxidation and PPARδ in amplifying glucose-stimulated insulin secretion. Diabetes, 60, 2830-2842.
82. Porter, N. A., Weber, B. A., Weenen, H., Khan, J. A. (1980) Autoxidation of polyunsaturated lipids. Factors controlling the stereochemistry of product hydroperoxides. Journal of the American Chemical Society, 102, 5597-5601.
83. Halliwell, B., Chirico, S. (1998) Lipid peroxidation: its mechanism, measurement, and significance. American Journal of Clinical Nutrition, 57, 715S-725S.
84. Weber, D., Milkovic, L., Bennett, S. J., et al. (2013) Measurement of HNE-protein adducts in human plasma and serum by ELISA-comparison of two primary antibodies. Redox Biology, 1, 226-233.
85. Lindschinger, M., Nadlinger, K., Adelwöhrer, N., et al. (2004) Oxidative stress: potential of distinct peroxide determination systems. Clinical Chemistry and Laboratory Medicine, 42, 907-914.
86. Niki, E. (2009) Lipid peroxidation. Physiological levels and dual biological effects. Free Radical Biology & Medicine, 47, 469-484.
87. Roberts, L. J. II, Morrow, J. D. (1997) The generation and actions of isoprostanes. Biochimica et Biophysica Acta, 1345, 121-135.
88. Montuschi, P., Barnes, P., Roberts, L. J. II (2007) Insights into oxidative stress: the isoprostanes. Current Medicinal Chemistry, 14, 703-717.
89. Witztum, J. L., Steinberg, D. (1991) Role of oxidized low density lipoprotein in atherogenesis. Journal of Clinical Investigation, 88, 1785-1792.
90. Berliner, J. A., Navab, M., Fogelman, A. M., et al. (1995) Atherosclerosis: basic mechanisms. Oxidation, inflammation, and genetics. Circulation, 91, 2488-2496.
91. Milne, G. L., Porter, N. A. (2001) Separation and identification of phospholipid peroxidation products. Lipids, 36, 1265-1275.
92. Spiteller, G. (2005) Is atherosclerosis a multifactorial disease or is it induced by a sequence of lipid peroxidation reactions? Annals of the New York Academy of Sciences, 1043, 355-366.
93. Spiteller, G. (2006) Peroxyl radicals: inductors of neurodegenerative and other inflammatory diseases. Their origin and how they transform cholesterol, phospholipids, plasmalogens, polyunsaturated fatty acids, sugars, and proteins into deleterious products. Free Radical Biology & Medicine, 41, 362-387.
94. Melchiorre, M., Torreggiani, A., Chatgilialoglu, C., Ferreri, C. (2011) Lipid markers of geometrical radical stress: synthesis of mono-trans cholesteryl ester isomers and detection in human plasma. Journal of the American Chemical Society, 133, 15184-15190.
95. Eichelbaum, M., Ingelman-Sundberg, M., Evans, W. E. (2006) Pharmacogenomics and individualized drug therapy. Annual Review of Medicine, 57, 119-137.
96. Polychronakos, C., Li, Q. (2011) Understanding type 1 diabetes through genetics: advances and prospects. Nature Reviews Genetics, 12, 781-792.
97. Lobo, I. (2008) Environmental influences on gene expression. Nature Education, 1, 39.
98. Choi, S.-W., Friso, S. (2010) Epigenetics: a new bridge between nutrition and health. Advances in Nutrition, 1, 8-16.
99. Penders, B., Goven, J. (2010) Nutrigenomics and the stewardship of scientific promises. Biotechnology Journal, 5, 909-912. doi: 10.1002/biot.201000069.
100. Deckelbaum, R. J., Worgall, T. S., Seo, T. (2006) n-3 fatty acids and gene expression. American Journal of Clinical Nutrition, 83, 1520S-1525S.
101. Chatgilialoglu, C., Ferreri, C. (2012) Nutrilipidomics: a tool for personalized health. Journal of Glycomics & Lipidomics, 2, 3. http://dx.doi.org/10.4172/2153- 0637.1000e109 (accessed 10 January 2015).
102. Serham, C. N. (2005) Mediator lipidomics. Prostaglandins & Other Lipid Mediators, 77, 4-14.
103. Arita, M., Iwamoto, R., Isobe, Y. (2012) Mediator lipidomics in inflammation, in Lipidomics (ed. K. Ekroos). Wiley-VCH Verlag & Co KGaA, Weinheim, pp. 219-230.
104. Goldring, C., Kitteringham, N., Jenkins, R., Copple, I., Jeannin, J.-F., Kevin Park, B. (2006) Plasticity in cell defence: access to and reactivity of critical protein residues and DNA response elements. Journal of Experimental Biology, 209, 2337-2343.
105. Vousden, K. H., Ryan, K. M. (2009) p53 and metabolism. Nature Reviews Cancer, 9, 691-700.
106. Roda, G., Sartini, A., Zambon, E., et al. (2010) Intestinal epithelial cells in inflammatory bowel diseases. World Journal of Gastroenterology, 16, 4264-4271.
107. Wolowczuk, I., Verwaurde, C., Viltart, O., et al. (2008) Feeding our immune system: impact on metabolism. Clinical and Developmental Immunology, 2008, 639803.
108. Netea, M. G., Wijmenga, C., O'Neill, L. A. (2012) Genetic variation in Toll-like receptors and disease susceptibility. Nature Immunology, 13, 535-542.
109. Claypool, S. M., Koehler, C. M. (2012) The complexity of cardiolipin in health and disease. Trends in Biochemical Sciences, 37, 32-41.
110. Makrides, M., Neumann, M. A., Byard, R. W., Simmer, K., Gibson, R. A. (1994) Fatty acid composition of brain, retina, and erythrocytes in breast- and formulafed infants. American Journal of Clinical Nutrition, 60, 189-194.
111. Baur, L. A., O'Connor, J., Pan, D. A., Wu, B. J., O'Connor, M. J., Storlien, L. H. (2010) Relationships between the fatty acid composition of muscle and erythrocyte membrane phospholipid in young children and the effect of type of infant feeding. Lipids, 35, 77-82.
112. Ogura, T., Takada, H., Okuno, M., et al. (2010) Fatty acid composition of plasma, erythrocytes and adipose: their correlations and effects with age and sex. Lipids, 45, 137-144.
113. Willet, W. (2013) Nutritional Epidemiology. Oxford University Press, Oxford.
114. Quehenberger, O., Armando, A. M., Brown, A. H., et al. (2010) Lipidomics reveals a remarkable diversity of lipids in human plasma. Journal of Lipid Research, 51, 3299-3305.
115. Risè, P., Eligini, S., Ghezzi, S., Colli, S., Galli, C. (2007) Fatty acid composition of plasma, blood cells and whole blood: relevance for the assessment of the fatty acid status in humans. Prostaglandins, Leukotrienes, and Essential Fatty Acids, 76, 363-369.
116. Piomelli, S., Seaman, C. (1993) Mechanism of red blood cell aging: relationship of density and cell age. American Journal of Hematology, 42, 46-52.
117. Ferreri, C., Samadi, A., Sassatelli, F., Landi, L., Chatgilialoglu, C. (2004) Regioselective cis-trans isomerization of arachidonic double bonds by thiyl radicals: the influence of phospholipid supramolecular organization. Journal of the American Chemical Society, 126, 1063-1072.
118. Ferreri, C. (2008) Method for the evaluation of the functional status of cell membranes referred to the fatty acid components. European Patent Application EP2356468.
119. Itoh, S., Taketomi, A., Harimoto, N., et al. (2010) Antineoplastic effects of gamma linolenic acid on hepatocellular carcinoma cell lines. Journal of Clinical Biochemistry and Nutrition, 47, 81-90.
120. EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA) (2012) Scientific opinion on the tolerable upper intake level of eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA) and docosapentaenoic acid (DPA). EFSA Journal, 10, 2815.
121. EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA) (2009) Labelling reference intake values for n-3 and n-6 polyunsaturated fatty acids. EFSA Journal, 1176, 1-11.
122. Halliwell, B. (2000) The antioxidant paradox. Lancet, 355, 1179-1180.
123. McNeil, P. L., Terasaki, M. (2001) Coping with the inevitable: how cells repair a torn surface membrane. Nature Cell Biology, 3, E124-E129.
124. Simopoulos, A. P. (1999) Essential fatty acids in health and chronic disease. American Journal of Clinical Nutrition, 70(Suppl), 560S-569S.
125. Storlien, L. H., Hulbert, A. J., Else, P. L. (1998) Polyunsaturated fatty acids, membrane function and metabolic diseases such as diabetes and obesity. Current Opinion in Clinical Nutrition & Metabolic Care, 1, 559-563.
126. Zierath, J. R., Houseknecht, K. L., Gnudi, L., Kahn, B. B. (1997) High-fat feeding impairs insulin-stimulated GLUT4 recruitment via an early insulin-signalling defect. Diabetes, 177, 343-349.
127. Andersson, A., Sjödin, A., Olsson, R., Vessby, B. (1998) Effects of physical exercise on phospholipid fatty acid composition skeletal muscle. American Journal of Physiology, 274, E432-E438.
128. Simopoulos, A. P. (2007) Omega-3 fatty acids and athletics. Current Sports Medicine Reports, 6, 230-236.
129. Ji, L. L., Leichtweis, S. (1997) Exercise and oxidative stress: sources of free radicals and their impact on antioxidant systems. Age, 20, 91-106.
130. Dekkers, J. C., van Doornen, L. J., Kemper, H. C. (1996) The role of antioxidant vitamins and enzymes in the prevention of exercise-induced muscle damage. Sports Medicine, 21, 213-238.
131. Sjodin, T., Westing, Y. H., Apple, F. S. (1990) Biochemical mechanisms for oxygen free radical formation during exercise. Sports Medicine, 10, 236-254.
132. Clarkson, P. M. (1995) Antioxidants and physical performance. Critical Reviews in Food Science and Nutrition, 35, 131-141.
133. Goldfarb, A. H. (1999) Nutritional antioxidants as therapeutic and preventive modalities in exercise-induced muscle damage. Canadian Journal of Applied Physiology, 24, 249-266.
134. Gomez-Cabrera, M. C., Domenech, E., Viña, J. (2008) Moderate exercise is an antioxidant: upregulation of antioxidant genes by training. Free Radical Biology & Medicine, 44, 126-131.
135. Al, D. M. M., von Houwelingen, A. C., Hornstra, G. (2000) Long-chain polyunsaturated fatty acids, pregnancy, and pregnancy outcome. American Journal of Clinical Nutrition, 71, 285S-291S.
136. Helland, I. B., Saugstad, O. D., Smith, L., et al. (2001) Similar effects on infants of n-3 and n-6 fatty acids supplementation to pregnant and lactating women. Pediatrics, 108, 82-92.
137. Ravelli, G. P., Stein, Z. A., Susser, M. W. (1976) Obesity in young men after famine exposure in utero and early infancy. New England Journal of Medicine, 295, 349-353.
138. Stein, A. D., Pierik, F. H., Verrips, G. H. W., Susser, E. S., Lumey, L. H. (2009) Maternal exposure to the Dutch Famine before conception and during pregnancy: quality of life and depressive symptoms in adult offspring. Epidemiology, 20, 909-915.
139. Kyle, U. G., Pichard, C. (2006) The Dutch Famine of 1944-1945: a pathophysiological model of long-term consequences of wasting disease. Current Opinion in Clinical Nutrition & Metabolic Care, 9, 388-394.
140. Koletzko, B. (2001) Fatty acids and early human growth. American Journal of Clinical Nutrition, 73, 671-672.
141. Cohen, J. F. W., Rifas-Shiman, S. L., Rimm, E. B., Oken, E., Gillman, M. W. (2011) Maternal trans fatty acid intake and fetal growth. American Journal of Clinical Nutrition, 94, 1241-1247.
142. Decsi, T., Boehm, G. (2013) trans Isomeric fatty acids are inversely related to the availability of long-chain PUFAs in the perinatal period. American Journal of Clinical Nutrition, 98, 543S-548S.
143. Hulbert, A. J. (2008) Explaining longevity of different animals: is membrane fatty acid composition the missing link? Age, 30, 89-97.
144. Puca, A. A., Andrew, P., Novelli, V., et al. (2008) Fatty acid profile of erythrocyte membranes as possible biomarker of longevity. Rejuvenation Research, 11, 63-72.
145. Saito, M., Kubo, K. (2003) Relationship between tissue lipid peroxidation and peroxidizability index after α-linolenic, eicosapentaenoic, or docohexaenoic acid intake in rats. British Journal of Nutrition, 89, 19-28.
146. Franceschi, C., Capri, M., Monti, D., et al. (2007) Inflammaging and anti-inflammaging: a systemic perspective on aging and longevity emerged from studies in humans. Mechanisms of Ageing and Development, 128, 92-105.
147. Freund, A., Orjalo, A. V., Desprez, P.-Y., Campisi, J. (2010) Inflammatory networks during cellular senescence: causes and consequences. Trends in Molecular Medicine, 16, 238-246.
148. Mozaffarian, D. (2005) Effects of dietary fats versus carbohydrates on coronary heart disease: a review of the evidence. Current Atherosclerosis Reports, 7, 435-445.
149. Salter, A. M., White, D. A. (1996) Effects of dietary fat on cholesterol metabolism: regulation of plasma LDL concentration. Nutrition Research Reviews, 9, 241-257.
150. Mensink, R. P., Zock, P. L., Kester, A. D. M., Katan, M. B. (2003) Effects of dietary fatty acids and carbohydrates on the ratio of serum total to HDL cholesterol and on serum lipids and apolipoproteins: a meta-analysis of 60 controlled trials. American Journal of Clinical Nutrition, 77, 1146-1155.
151. Hu, F. (2010) Are refined carbohydrates worse than saturated fat? American Journal of Clinical Nutrition, 91, 1541-1542.
152. Breslow, J. L. (2006) N-3 fatty acids and cardiovascular diseases. American Journal of Clinical Nutrition, 83, 1477S-1482S.
153. Viviani Anselmi, C., Ferreri, C., Novelli, V., et al. (2010) Fatty acid percentage in erythrocyte membranes of atrial flutter/fibrillation patients and controls. Journal of Interventional Cardiac Electrophysiology, 27, 95-99.
154. Serhan, C. N., Hamberg, M., Samuelsson, B. (1984) Lipoxins: novel series of biologically active compounds formed from arachidonic acid in human leukocytes. Proceedings of the National Academy of Sciences of the United States of America, 81, 5335-5339.
155. Bhardwaj, S., Passi, S. J., Misra, A. (2011) overview of trans fatty acids: biochemistry and health effects. Diabetes & Metabolic Syndrome, 5, 161-164.
156. Mozaffarian, D., Katan, M. B., Ascherio, A., Stampfer, M. J., Willett, W. C. (2006) trans fatty acids and cardiovascular disease. New England Journal of Medicine, 354, 1601-1613.
157. Mozaffarian, D., Rimm, E. B., King, I. B., Lawler, R. L. McDonald, G. B., Levy, W. C. (2004) trans fatty acids and systemic inflammation in heart failure. American Journal of Clinical Nutrition, 80, 1521-1525.
158. Websites on trans fats: www.bantransfats.com; http://www.fda.gov.
159. Ng, M., Fleming, T., Robinson, M., et al. (2014) Global, regional, and national prevalence of overweight and obesity in children and adults during 1980-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet, 384, 766-781.
160. OECD. Obesity update 2012. http://www.oecd.org/els/health-systems/49716427. pdf (accessed 10 January 2015).
161. Cypess, A. M., Lehman, S., Williams, G., et al. (2009) Identification and importance of brown adipose tissue in adult humans. New England Journal of Medicine, 360, 1509-1517.
162. Okada, T., Furuhashi, N., Kuromori, Y., Miyashita, M., Iwata, F., Harada, K. (2005) Plasma palmitoleic acid content and obesity in children. American Journal of Clinical Nutrition, 82, 747-750.
163. Mozaffarian, D., Cao, H., King, I. B., et al. (2010) Circulating palmitoleic acid and risk of metabolic abnormalities and new-onset diabetes. American Journal of Clinical Nutrition, 92, 1350-1358.
164. Zong, G., Ye, X., Sun, L., et al. (2012) Association of erythrocyte palmitoleic acid with adipokines, inflammatory markers, and the metabolic syndrome in middleaged and older Chines. American Journal of Clinical Nutrition, 96, 970-976.
165. Caspar-Bauguil, S., Fioroni, A., Galinier, A., et al. (2012) Pro-inflammatory phospholipid arachidonic acid/eicosapentaenoic acid ratio of dysmetabolic severely obese women. Obesity Surgery, 22, 935-944.
166. Muhlhausler, B. S., Ailhaud, G. P. (2013) Omega-6 polyunsaturated fatty acids and the early origins of obesity. Current Opinion in Endocrinology, Diabetes and Obesity, 20, 56-61.
167. Lorente-Cebrian, S., Costa, A. G. V., Navas-Carretero, S., Zabala, M., Martinez, J. A., Moreno-Aliaga, M. J. (2013) Role of omega-3 fatty acids in obesity, metabolic syndrome, and cardiovascular diseases: a review of the evidence. Journal of Physiology and Biochemistry, 69, 633-651.
168. Sampath, H., Ntambi, J. M. (2014) Role of stearoyl-CoA-desaturase-1 in skin integrity and whole energy balance. Journal of Biological Chemistry, 289, 2482-2488.
169. Ge, L., Gordon, J. S., Hsuan, C., Stenn, K., Prouty, S. M. (2003) Identification of the delta-6 desaturase of human sebaceous glands: expression and enzyme activity. Journal of Investigative Dermatology, 120, 707-714.
170. Williard, D. E., Nwankwo, J. O., Kaduce, T. L., et al. (2001) Identification of a fatty acid delta6-desaturase deficiency in human skin fibroblasts. Journal of Lipid Research, 42, 501-508.
171. Kwochka, K. W. (1993) The structure and function of epidermal lipids. Veterinary Dermatology, 4, 151-159.
172. Fuchs, J., Packer, L. (eds.) (1993) Oxidative Stress in Dermatology. Marcel Dekker, New York.
173. Jungersted, J. M., Hellgren, L. I., Jemec, G. B., Agner, T. (2008) Lipids and skin barrier function: a clinical perspective. Contact Dermatitis, 58, 255-262.
174. Wolters, M. (2005) Diet and psoriasis: experimental data and clinical evidence. British Journal of Dermatology, 153, 706-714.
175. Devereux, G., Seaton, A. (2005) Diet as a risk factor for atopy and asthma. Journal of Allergy and Clinical Immunology, 115, 1109-1117.
176. Brown, A. C., Hairfield, M., Richards, D. G., McMillin, D. L., Mein, E. A., Nelson, C. D. (2004) Medical nutrition therapy as a potential complementary treatment for psoriasis-five case report. Alternative Medicine Review, 9, 297-307.
177. Valko, M., Leibfritz, D., Moncol, J., Cronin, M. T., Mazur, M., Telser, J. (2007) Free radicals and antioxidants in normal physiological functions and human disease. International Journal of Biochemistry & Cell Biology, 39, 44-84.
178. Briganti, S., Picardo, M. (2003) Antioxidant activity, lipid peroxidation and skin diseases. What's new. Journal of the European Academy of Dermatology and Venereology, 17, 663-669.
179. Trautinger, F. (2001) Mechanisms of photodamage of the skin and its functional consequences for skin ageing. Clinical and Experimental Dermatology, 26, 573-577.
180. Podda, M., Grundmann-Kollmann, M. (2001) Low molecular weight antioxidants and their role in skin ageing. Clinical and Experimental Dermatology, 26, 578-582.
181. Ferreri, C., Angelini, F., Chatgilialoglu, C., et al. (2005) trans fatty acids and atopic eczema/dermatitis syndrome: the relationship with a free radical cis-trans isomerization of membrane lipids. Lipids, 40, 661-667.
182. Suarez, A., Ramirez, M. C., Faus, M. J. (1994) The effect of dietary supplementation with long-chain polyunsaturated fatty acids of the n-3 and n-6 series and with vitamin E on the plasma fatty acid profiles. Nutrición Hospitalaria, 9, 170-180.
183. Soyland, E., Funk, J., Rajka, G., et al. (1993) Effect of dietary supplementation with very long chain n-3 fatty acids in patients with psoriasis. New England Journal of Medicine, 328, 1812-1816.
184. Mayser, P., Mrowietz, U., Arenberger, P., et al. (1998) N-3 fatty acid-based lipid infusion in patients with chronic plaque psoriasis: results of a double-blind, randomized, placebo-controlled multicenter trial. Journal of the American Academy of Dermatology, 38, 539-547.
185. Bittiner, S. B., Tucker, W. F., Cartwright, I., Bleehen, S. S. (1988) A double-blind, randomised, placebo-controlled trial of fish oil in psoriasis. Lancet, 20, 378-380.
186. Hofacer, R., Jandacek, R., Rider, T., et al. (2011) Omega-3 fatty acid deficiency selectively up-regulates delta6-desaturase expression and activity indices in rat liver: prevention by normalization of omega-3 fatty acid status. Nutrition Research, 31, 715-722.
187. Cook, H. W., McMaster, C. R. (2002) Fatty acid desaturation and chain elongation in eukaryotes, in: Biochemistry of Lipids, Lipoproteins and Membranes, 4th ed. (eds. D. E. Vance, J. E. Vance). Elsevier, Amsterdam, pp. 181-204.
188. Bradbury, J. (2011) Docosahexaenoic acid (DHA): an ancient nutrient for the modern human brain. Nutrients, 3, 529-554.
189. McCann, J. C., Ames, B. N. (2005) Is docosahexaenoic acid, an n-3 long-chain polyunsaturated fatty acid, required for development of normal brain function? An overview of evidence from cognitive and behavioral tests in humans and animals. American Journal of Clinical Nutrition, 82, 281-295.
190. Montgomery, C., Speake, B. K., Cameron, A., Sattar, N., Weaver, L. T. (2003) Maternal docosahexaneoic acid supplementation and fetal accretion. British Journal of Nutrition, 90, 135-145.
191. Jensen, C. L., Vogit, R. G., Prager, T. C., et al. (2005) Effects of maternal docosahexaenoic acid intake on visual function and neurodevelopment in breastfed term infants. American Journal of Clinical Nutrition, 82, 125-132.
192. Gibson, R. A., Neumann, M. A., Makrides, M. (1997) Effect of increasing milk docosahexaenoic acid on plasma erythrocyte phospholipid fatty acids and neural indices of exclusively breast fed infants. European Journal of Clinical Nutrition, 51, 578-584.
193. Pagan, A., Prieto-Sanchez, M. T., Blanco-Carnero, J. E., et al. (2013) Materno-fetal transfer of docosahexaenoic acid is impaired by gestational diabetes mellitus. American Journal of Physiology. Endocrinology and Metabolism, 305, E826-E833.
194. Bazan, N. G. (2005) Neuroprotectin D1 (NPD1): a DHA-derived mediator that protects brain and retina against cell injury-induced oxidative stress. Brain Pathology, 15, 159-166.
195. Horrocks, L. A., Farooqui, A. A. (2004) Docosahexaenoic acid in the diet: its importance in maintenance and restoration of neural membrane function. Prostaglandins, Leukotrienes and Essential Fatty Acids, 70, 361-372.
196. Kalmijn, S., Launer, L. J., Ott, A., Witteman, J. C., Hofman, A., Breteler, M. M. (1997) Dietary fat intake and the risk of incident dementia in the Rotterdam study. Annals of Neurology, 42, 776-782.
197. Laitinen, M. H., Ngandu, T., Rovio, S., et al. (2006) Fat intake at midlife and risk of dementia and Alzheimer's disease: a population-based study. Dementia and Geriatric Cognitive Disorders, 22, 99-107.
198. Teixtera, A. M., Dias, V. T., Pase, C. S., et al. (2012) Could dietary trans fatty acids induce movement disorders? Effects of exercise and its influence on Na+-K+-ATPase and catalase activity in rat striatum. Behavioural Brain Research, 226, 504-510.
199. Mary, A., Serre, I., Brun, J. F. (1993) Erythrocyte deformability measurements in patients with glaucoma. Journal of Glaucoma, 2, 155-157.
200. Schachtschabel, U., Lindsey, J. D., Weinreb, R. N. (2000) The mechanism of action of prostaglandins on uveoscleral outflow. Current Opinion in Ophthalmology, 11, 112-115.
201. Stjernschantz, J. W. (2001) From PGF(2-alpha)-isopropyl ester to latanoprost: a review of the development of Xalatan. Investigative Ophthalmology & Visual Science, 42, 1134-1145.
202. Nguyen, C. T., Bui, B. V., Sinclair, A. J., Vingrys, A. J. (2007) Dietary omega 3 fatty acids decrease intraocular pressure with age by increasing aqueous outflow. Investigative Ophthalmology & Visual Science, 48, 756-762.
203. Weinreb, R. N., Toris, C. B., Gabelt, B. T., Lindsey, J. D., Kaufman, P. L. (2002) Effects of prostaglandins on the aqueous humor outflow pathways. Survey of Ophthalmology, 47, S53-S64.
204. Ren, H., Magulike, N., Ghebremeskel, K., Crawford, M. (2006) Primary openangle glaucoma patients have reduced levels of blood docohaenoic and eicosapentaenoic acids. Prostaglandins, Leukotrienes and Essential Fatty Acids, 74, 157-163.
205. Birch, E. E., Birch, D. G., Hoffman, D. R., Uauy, R. (1992) Dietary essential fatty acid supply and visual acuity development. Investigative Ophthalmology & Visual Science, 33, 3242-3253.
206. Rotstein, N. P., Aveldano, M. I., Politi, L. E. (1998) Docosahexaenoic acid promotes differentiation of developing photoreceptors in vitro. Investigative Ophthalmology & Visual Science, 39, 2750-2758.
207. Tanito, M., Brush, R. S., Elliott, M. H., Wicker, L. D., Henry, K. R., Anderson, R. E. (2009) High levels of retinal docosahexaenoic acid increase susceptibility to stressinduced degeneration. Journal of Lipid Research, 50, 807-819.
208. Ghezzo, A., Visconti, P., Abruzzo, P. M., et al. (2013) Oxidative stress and erythrocyte membrane alterations in children with autism: correlation with clinical features. PLoS ONE, 8, e66418.
209. Riezzo, G., Ferreri, C., Orlando, A., Martulli, M., D'Attoma, B., Russo, F. (2014) Lipidomic analysis of fatty acids in erythrocytes of coeliac patients before and after a gluten-free diet intervention: a comparison with healthy subjects. British Journal of Nutrition, 112, 1787-1796. http://dx.doi.org/10.1017/S0007114514002815 (accessed 10 January 2015).